Tanezumab Biosimilar, NGF Monoclonal Antibody

Tanezumab Biosimilar, NGF Monoclonal Antibody

$175.00$960.00

In stock

$175.00$960.00

Tanezumab Biosimilar, NGF Monoclonal Antibody. The research grade tanezumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.

SKU: C110P
Clear
View cart
Catalog No. C110P
Product NameTanezumab Biosimilar, NGF Monoclonal Antibody
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Synonyms Nerve Growth Factor
Summary Recombinant Humanized IgG2 Monoclonal Antibody.
Isotype Human IgG2 kappa.
Source/Host The anti-human NGF monoclonal antibody tanezumab biosimilar was produced in mammalian cells.
Specificity/Sensitivity The in vivo grade tanezumab biosimilar specifically binds to the NGF protein.
Form Of Antibody 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin < 1 EU per 1 mg of the protein by the LAL method.
Purity >95% by SDS-PAGE under reducing conditions and HPLC.
Shipping The research grade tanezumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note The research grade tanezumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C110P: Tanezumab Biosimilar, NGF Monoclonal Antibody
Recombinant Humanized IgG2 Monoclonal Antibody.

Background
What is tanezumab biosimilar research grade? Tanezumab is a humanized IgG2-kappa monoclonal antibody against nerve growth factor (NGF) as a treatment for pain via a novel mechanisms different from conventional pain-killer drugs. NGF levels increase in the body as a result of injury, inflammation or in chronic pain states. Tanezumab selectively targets, binds to, and inhibits NGF. Tanezumab acts in the periphery in a different manner than opioids and other analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs), and in studies to date, tanezumab has not demonstrated a risk of addiction, misuse or dependence. Tanezumab biosimilar uses the same protein sequences as the therapeutic antibody tanezumab.

Syd Labs provides the following research grade antibody biosimilars used in ADCs:
Tusamitamab biosimilar, research grade, anti-human CEACAM5 monoclonal antibody
Rovalpituzumab biosimilar, research grade, anti-human DLL3 monoclonal antibody
Trastuzumab biosimilar, research grade, anti-human HER2 monoclonal antibody
Cofetuzumab biosimilar, research grade, anti-human PTK7 monoclonal antibody
Ifinatamab biosimilar, research grade, anti-human B7-H3 (CD276) monoclonal antibody
Sacituzumab biosimilar, research grade, anti-human Trop-2 monoclonal antibody
Gemtuzumab biosimilar, research grade, anti-human CD33 monoclonal antibody
Polatuzumab biosimilar, research grade, anti-human CD79B monoclonal antibody
Cetuximab biosimilar, research grade, anti-human EGFR monoclonal antibody

Please remember our product information: Tanezumab Biosimilar, NGF Monoclonal Antibody: C110P Syd Labs

Additional information

Ship from Country

USA

Size

1 mg, 20 mg, 5 mg

No more offers for this product!